Study to Assess Safety and Efficacy of Oral Senicapoc Administration on Exercise-induced Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

July 31, 2009

Study Completion Date

September 30, 2009

Conditions
Exercise Induced Asthma
Interventions
DRUG

senicapoc

Loading Dose: 80 mg twice daily x 3 days Maintenance Dose: 40 mg daily for remainder of the treatment period (total 4 weeks)

DRUG

Placebo

Placebo looks identical to active study medication and will be dosed according to the same dosing regimen

Trial Locations (9)

13212

North Syracuse

44718

Canton

61761

Normal

63141

St Louis

70006

Metairie

92647

Huntington Beach

92868

Orange

98105

Seattle

08558

Skillman

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Icagen

INDUSTRY